{"nct_id":"NCT01362296","title":"An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer","status":"COMPLETED","status_verified_date":"2014-06","start_date":"2011-09","start_date_type":null,"primary_completion_date":"2012-09","primary_completion_date_type":"ACTUAL","completion_date":"2013-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}